In fiscal 2026, which ended Mar 31, 2026, Modular Medical, Inc. used $23.8 million of cash from operations, down 51.1% from the year before. It spent $3.9 million on capital expenditures. Free cash flow was negative, at -$27.7 million.
USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.
| Line |
FY 2027
Jun 30, 2026
|
FY 2026
Mar 31, 2026
|
FY 2025
Mar 31, 2025
|
FY 2024
Mar 31, 2024
|
FY 2023
Mar 31, 2023
|
FY 2022
Mar 31, 2022
|
FY 2021
Mar 31, 2021
|
FY 2020
Mar 31, 2020
|
FY 2019
Mar 31, 2019
|
FY 2018
Mar 31, 2018
|
FY 2017
Jun 30, 2017
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | |||||||||||
| Depreciation and amortization |
2
+38.1%
|
2
+57.3%
|
1
+149.5%
|
0
+180.3%
|
0
+29.4%
|
0
+5.8%
|
0
+213.3%
|
0
+144.9%
|
0
+677.4%
|
0
|
—
|
| Stock-based compensation |
2
-41.6%
|
2
-25.3%
|
2
-11.8%
|
3
-0.8%
|
3
-32.4%
|
4
+228.4%
|
1
+53.2%
|
1
+50.6%
|
1
|
—
|
—
|
| Operating cash flow |
-24
-38.8%
|
-24
-51.1%
|
-16
-12.7%
|
-14
-26.7%
|
-11
-7.3%
|
-10
-73.6%
|
-6
-44.3%
|
-4
-126.5%
|
-2
-128.5%
|
-1
-734.4%
|
-0
-789.1%
|
| Investing | |||||||||||
| Capital expenditures |
4
+42.6%
|
4
+57.7%
|
2
+46.6%
|
2
+3.8%
|
2
+2891.0%
|
0
-50.1%
|
0
-57.9%
|
0
+238.1%
|
0
+410.1%
|
0
|
—
|
| Investing cash flow |
-4
-42.6%
|
-4
-57.7%
|
-2
-46.6%
|
-2
-3.8%
|
-2
-2891.0%
|
-0
+50.1%
|
-0
+57.9%
|
-0
-238.1%
|
-0
-403.0%
|
-0
|
0
|
| Financing | |||||||||||
| Stock buybacks |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0
-100.0%
|
0
|
| Financing cash flow |
24
+8.1%
|
22
-2.5%
|
22
+4.7%
|
21
+186.0%
|
7
-58.9%
|
18
+310.6%
|
4
+372.4%
|
1
-77.7%
|
4
-12.1%
|
5
+221.1%
|
1
+13659.8%
|
| Change in cash | |||||||||||
| Net change in cash |
—
|
—
|
—
|
—
|
-5
-169.4%
|
8
|
—
|
—
|
—
|
—
|
—
|
| Free cash flow |
-28
-39.3%
|
-28
-52.0%
|
-18
-16.4%
|
-16
-23.7%
|
-13
-22.6%
|
-10
-71.4%
|
-6
-38.2%
|
-4
-131.1%
|
-2
-133.8%
|
-1
|
—
|
| Per share | |||||||||||
| Free cash flow per share |
-8.80
-392.9%
|
-12.12
+18.0%
|
-14.77
-2011.8%
|
-0.70
+33.1%
|
-1.05
|
—
|
—
|
—
|
-0.11
-88.0%
|
-0.06
|
—
|
| Shareholder returns | |||||||||||
| Returned to shareholders |
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
—
|
0
|
0
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- MODD (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- NV
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1074871
- Former names
- BEAR LAKE RECREATION INC (until May 25, 2017)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.